 |
Common Tradenames (See Complete Tradename Listing)
 |
PROCAN SR |
|
PROCANBID |
|
PRONESTYL |
|
|
Class
|
antiarrhythmic, group ia |
|
|
Dosage, Adult (usual)
|
50mg/kg PO DAILY (divide Q6-12H) |
|
IV initial MAX rate 50mg/min up to MAX dose of 1gram, then maintenance infusion 2-6mg/min |
|
|
Dosage, Pediatric, (usual)
|
50-125mg/kg PO DAILY (divide Q3-6H); MAX dose 4G/day |
|
IV 10-15mg/kg over 15min then 20- 80mcg/kg/min OR 50-100mg/kg/24hr(divided Q4h); MAX 2G/24h |
|
|
Dose Adjustments:
|
liver disease, renal impairment |
|
|
How Supplied
|
250 MG, 375 MG, 500 MG CAPSULE |
|
1000 MG, 500 MG EXTENDED-RELEASE TABLET |
|
1000 MG, 250 MG, 500 MG, 750 MG SUSTAINED-RELEASE TABLET |
|
|
Indications
|
arrhythmias |
|
|
Contraindications
|
hypersensitivity to procainamide, procaine/local anesthetics |
|
heart block |
|
SLE |
|
Torsades de Pointes |
|
|
Adverse Effects
|
myelosuppression |
|
neuropathy |
|
SLE |
|
N/V |
|
diarrhea |
|
dizziness |
|
|
Drug Interactions
|
